Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | TNF-a | 100 | ng/mL | 1 | MMP-2 | 950.0 | 17 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MMP-2 | 380.0 | 30 | |
N2759 | TNF-a | 100 | ng/mL | 1 | MMP-2 | 379.0 | 50 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MMP-2 | 493.5 | 26 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | MMP-2 | 930.0 | 47 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | MMP-2 | 773.0 | 23 | |
N2586 | TNF-a | 100 | ng/mL | 1 | MMP-2 | 322.0 | 9 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 444.0 | 12 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 705.0 | 35 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 178.0 | 39 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 356.0 | 28 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 334.0 | 48 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 426.0 | 11 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 295.5 | 30 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 243.0 | 25 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 553.5 | 60 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 786.0 | 29 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 293.0 | 21 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 374.0 | 27 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 661.5 | 12 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 441.0 | 37 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 622.0 | 40 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | MMP-2 | 334.0 | 16 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-2 | 626.0 | 25 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MMP-2 | 902.0 | 33 |